Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Tvb-2640

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascletis receives IND approval for its NASH drug
    Ascletis receives IND approval for its NASH drug

    28 Aug 2019

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/39/14348/ascletis-receives-ind-approval-for-its-nash-drug-.html

    BIOSPECTRUMASIA
    28 Aug 2019
    Share Share
    Ascletis, 3-V Biosciences Announce NASH Strategic License and Series E Financing
    Ascletis, 3-V Biosciences Announce NASH Strategic License and Series E Financing

    13 Feb 2019

    // PRESS RELEASE

    http://www.3vbio.com/ascletis-and-3-v-biosciences-announce-nash-strategic-license-and-series-e-financing/

    PRESS RELEASE
    13 Feb 2019
    Share Share
    Ascletis and 3-V Biosciences Announce NASH-License and Series E Financing
    Ascletis and 3-V Biosciences Announce NASH-License and Series E Financing

    12 Feb 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ascletis-and-3-v-biosciences-announce-nash-strategic-license-and-series-e-financing-300794599.html

    PR NEWSWIRE
    12 Feb 2019
    Share Share